Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Disposal

15 Feb 2005 14:32

Infast Group PLC15 February 2005 EXIT FROM MANUFACTURING COMPLETED Infast Group plc ("Infast" or the "Company") announces that today it completed amajor part of its strategic programme, announced in July 2004, with the sale ofthe assets and business of Infast Philidas Limited ("Philidas" or the"business"). The withdrawal from all manufacturing operations has been achieved: • At a financial impact less than expected in July 2004. The exceptional charge excluding goodwill realisation is expected to be around £7 million (pre-tax relief) compared to the £8 million announced in July 2004. • Earlier than previously expected. • Primarily by sale rather than closure. • Without impacting the availability of product to Infast's core services divisions. Graham Titcombe, Chairman of Infast said: "Having exited from manufacturing,Infast is now positioned to focus fully on its value added Inventory Managementbusinesses, which are located in Europe and North America. "Further, the property disposals relating to our exit from manufacturing arecurrently underway. The sale of these properties will generate significantadditional cash flow in 2005. This will be used to reduce the Company's debt." Disposal of Philidas Philidas, which is located at Pontefract in West Yorkshire, is a producer ofmetal fasteners. In the year ended 31 December 2004, the business had turnover of £7.9 millionand made a trading loss of £0.8 million. Under the terms of the sale, the purchaser will acquire the net trading assetsof the business for an initial cash consideration of £0.4 million, plus deferredconsideration, estimated to be £0.3 million, payable as product is supplied toInfast. Debt due to Philidas for goods recently supplied will not pass to thepurchaser. This is estimated to be a further £0.9 million, representing anadditional cash flow benefit to Infast. The book value of the net assets of thebusiness being sold is approximately £2.9 million. The purchaser has undertaken all employment and lease liabilities of Philidas. For further information, please contact Infast Group plc Tel: 01452 880 500Robert Sternick, Chief ExecutiveJohn Kimber, Finance Director Rawlings Financial PR Limited Tel: 01756 770 376John RawlingsCatriona Valentine This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Feb 201610:17 amRNSHolding(s) in Company
23rd Feb 20161:32 pmRNSResult of General Meeting and Director Dealings
12th Feb 20167:00 amRNSInvestor Presentation
5th Feb 20164:47 pmRNSIssue of Equity and Total Voting Rights
4th Feb 20167:00 amRNSDirector/PDMR Shareholding
3rd Feb 20167:00 amRNSPlacing, Posting of Circular and Notice of GM
25th Jan 20167:00 amRNSInnovators & Investors Forum
13th Jan 20167:00 amRNSTrading Update
23rd Dec 20151:15 pmRNSDirector Shareholding and Other Holdings
8th Dec 20153:53 pmRNSIssue of Equity and Total Voting Rights
1st Dec 20157:00 amRNSLogos Earn Out, Issue of Equity and TVR
30th Nov 20155:59 pmRNSHolding(s) in Company
29th Sep 20157:00 amRNSHalf Yearly Report
6th Aug 201511:55 amRNSAdmission of Ordinary Shares
3rd Aug 20157:00 amRNSLogos Third Earn Out Payment & Total Voting Rights
30th Jul 20157:00 amRNSTrading Update and Notice of Interim Results
29th Jul 20157:01 amRNSGrants Under the Long Term Incentive Plan
23rd Jun 20157:00 amRNSInvestor Teach-in
21st May 20154:39 pmRNSHolding(s) in Company
19th May 20151:16 pmRNSResult of AGM
14th May 20157:00 amRNSInstem ALPHADAS Contract Wins
27th Apr 20159:16 amRNSPosting of Annual Report and Notice of AGM
30th Mar 20157:00 amRNSFinal Results
16th Mar 20157:00 amRNSNotice of Results
13th Feb 20157:00 amRNSPerceptive Instruments Earn Out Payment
27th Jan 20157:01 amRNSInnovators & Investors Forum (London)
12th Jan 20157:00 amRNSTrading Update and Notice of Results
23rd Dec 201411:52 amRNSHolding(s) in Company
18th Dec 20147:00 amRNSWIL Research Contract Extension
10th Nov 20147:00 amRNSCentrus-submit Contract Wins
24th Sep 20147:00 amRNSUnaudited Interim Results
5th Sep 20147:00 amRNSNotice of Results
13th Aug 201410:27 amRNSHolding(s) in Company
1st Aug 20147:00 amRNSLogos Second Earn Out Payment
16th Jul 20147:00 amRNSTwo contract wins in Asia-Pacific
21st May 201411:45 amRNSResult of AGM
1st May 20147:00 amRNSContract win
25th Apr 20147:00 amRNSPosting of Annual Report and Notice of AGM
26th Mar 20147:01 amRNSUS Government Contract Extension
26th Mar 20147:00 amRNSFinal Results
6th Mar 20147:00 amRNSNotice of Results
20th Feb 20147:00 amRNSThree-Year SaaS Contract with Leading Pharma
7th Feb 20141:05 pmRNSHolding(s) in Company
3rd Feb 20147:00 amRNSLogos Initial Earn Out Payment
8th Jan 20147:00 amRNSTrading Update and Notice of Results
22nd Nov 20137:00 amRNSAcquisition and Trading Update
9th Oct 20137:00 amRNSAppointment of VP Global Sales
25th Sep 20137:00 amRNSHalf Yearly Report
15th Aug 20137:00 amRNSNotice of Results
2nd Jul 20137:00 amRNSFirst Contract Win for Instem Clinical

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.